Join
Live feed
·
INSIDERFilingvia Quantisnow
Relay Therapeutics Inc. logo

Officer Rahmer Peter sold $954,500 worth of shares (50,000 units at $19.09) as part of a pre-agreed trading plan and was granted 3,056 shares, decreasing direct ownership by 17% to 228,913 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track RLAY (Relay Therapeutics Inc.) and more on Quantisnow.

Officer Rahmer Peter sold $954,500 worth of shares (50,000 units at $19.09) as part of a pre-agreed trading plan and was granted 3,056 shares, decreasing direct ownership by 17% to 228,913 units (SEC Form 4) | Quantisnow